Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

AIDS/syringe exchange study

07.11.2002


Drug users with access to controversial syringe-exchange programs are up to six times less likely to put themselves at risk of HIV infection, according to a new UC Davis study published in the November issue of Journal of Acquired Immune Deficiency Syndromes.



"While programs to control the spread of HIV by providing clean needles to drug users remain controversial in California and around the country, this study clearly shows that syringe-exchange programs save lives -- and save society millions of dollars in health care costs required to treat HIV patients," said lead author David R. Gibson, associate professor of infectious and immunologic diseases at UC Davis and a senior scientist at UC San Francisco’s Center for AIDS Prevention Studies.

Injection drug use is linked to about one-third of all HIV/AIDS cases, according to the Centers for Disease Control and Prevention. Drug users contract these diseases by sharing contaminated syringes. To curb this high-risk behavior, syringe exchanges operate in a variety of settings, including storefronts, vans, sidewalk tables, health clinics, and places where drug users gather.


The first organized syringe-exchange programs in the United States were established in the late 1980s, despite strong opposition from some communities on moral grounds -- opposition that continues today.

"While this study should open the way to a more fact-based discussion of these controversial programs, a small, vocal minority simply refuses to look at the scientific evidence -- they are essentially ’data-proof,’" Gibson said.

The UC Davis study offers the most detailed examination to date of the complex factors of the role of syringe exchanges in reducing HIV risk behavior, Gibson said. The study addressed several key challenges that have tended to distort the findings of previous syringe-exchange studies, he added.

For instance, the study did a better job than previous studies had done in correcting for pre-existing differences between injecting drug users who seek to use a syringe-exchange program compared with those that do not. In addition, the study controlled for other sources of syringes that drug users may have and compared drug users who had other sources of syringes with those without other sources.

To adjust for these factors, the UC Davis researchers adopted more rigorous statistical controls than previous studies.

Among injecting drug users who already have some access to clean syringes, a syringe-exchange program results in a two-fold reduction in HIV risk behavior, said Gibson. For drug users with no other easy access to clean syringes, the benefits are even more significant -- a six-fold reduction in risk behaviors. Syringe-exchange programs will naturally appear less effective in communities with multiple sources of clean syringes compared to programs that constitute a community’s only supply.

"These findings underscore just how critical syringe exchange may be for all injecting drug users, but especially those who lack the resources or contacts to obtain syringes in other ways," said Gibson. "It also suggests syringe-exchange programs can be most effective in reducing HIV by focusing on getting sterile syringes to these most vulnerable drug users."

The findings are especially relevant in California in the wake of an intense debate over Senate Bill 1785, which would have allowed pharmacies to sell syringes to adults without a prescription. Gov. Gray Davis vetoed the bill in late September because it did not require a one-to-one needle exchange. Without this provision, Gov. Davis said, the bill could increase the number of contaminated needles and syringes in parks, beaches, and other public areas.

"Without access to clean syringes through pharmacies, injecting drug users must continue to rely on exchange programs to avoid high-risk behavior and curb the spread of HIV," said Gibson.

The study followed a group of 259 untreated injecting drug users in the San Jose area. Each of the participants was interviewed at the beginning of the study and then participated in follow-up interviews -- an average of about 11 months later. Some of the participants were clients of the San Jose syringe exchange, which used a mobile van to visit five sites frequented by injecting drug users.

The new study builds on a July 2001 UC Davis study, also lead by Gibson, which reviewed 42 studies on syringe-exchange programs from the United States, Canada, the United Kingdom and the Netherlands. The study concluded that previous studies often underestimated the effectiveness of syringe-exchange programs in communities where clean needles can be easily obtained from sources other than the syringe exchange. In addition, researchers have found that in areas where drug users have a choice between syringe exchange and legally obtaining syringes from pharmacies, the higher-risk users tend to gravitate to syringe-exchange programs. As a result, the syringe exchanges appear less effective when users of syringe exchange are compared with nonusers.

The first organized syringe-exchange programs in the United States were established in Tacoma, Washington; Portland, Oregon; San Francisco; and New York City. By 1997, there were 113 programs in more than 30 states, the District of Columbia, and Puerto Rico, which exchanged more than 17 million syringes, according to the Centers for Disease Control and Prevention.


###
Research was funded with a grant from the National Institute on Drug Abuse, United States Public Health Service.


Carole Gan | EurekAlert!
Further information:
http://www.ucdmc.ucdavis.edu/medical_center/index

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>